CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Trellis Bioscience secures Series C financing for TRL1068 trial

TRL1068Positive
AI Analysis

Summary

Trellis Bioscience closed a $9 million Series C round to fund the completion of its Phase 2 trial for TRL1068 (calpurbatug) in chronic PJI.

Clinical Trial Data

Phase

Phase 2

Importance:5/10
Sentiment:
0.60
Series C financingPhase 2 trialcapital raisechronic PJI
Related Companies

Read the original article

Published by Clinical Trials Arena on July 17, 2026 10:21 AM

Read Original